It would also be interesting to test the relationship between the HLA DQA1*05 allele and ATU, as it was previously reported that IBD patients carrying this allele were more likely to develop immunogenicity to anti-TNF therapy. Here, HLA-DQA2 is linked to inflammatory bowel disease.